title: Phosphorylation of IRS1 at serine 307 in response to insulin in human adipocytes is not likely to be catalyzed by p70 ribosomal S6 kinase.
abstract: The insulin receptor substrate-1 (IRS1) is phosphorylated on serine 307 (human sequence, corresponding to murine serine 302) in response to insulin as part of a feedback loop that controls IRS1 phosphorylation on tyrosine residues by the insulin receptor. This in turn directly affects downstream signaling and is in human adipocytes implicated in the pathogenesis of insulin resistance and type 2 diabetes. The phosphorylation is inhibited by rapamycin, a specific inhibitor of mammalian target of rapamycin (mTOR) in complex with raptor (mTORC1). The mTORC1-downstream p70 ribosomal protein S6 kinase (S6K1), which is activated by insulin, can phosphorylate IRS1 at serine 307 in vitro and is considered the physiological protein kinase. Because the IRS1 serine 307-kinase catalyzes a critical step in the control of insulin signaling and constitutes a potential target for treatment of insulin resistance, it is important to know whether S6K1 is the physiological serine 307-kinase or not. We report that, by several criteria, S6K1 does not phosphorylate IRS1 at serine 307 in response to insulin in intact human primary adipocytes: (i) The time-courses for phosphorylation of S6K1 and its phosphorylation of S6 are not compatible with the phosphorylation of IRS1 at serine 307; (ii) A dominant-negative construct of S6K1 inhibits the phosphorylation of S6, without effect on the phosphorylation of IRS1 at serine 307; (iii) The specific inhibitor of S6K1 PF-4708671 inhibits the phosphorylation of S6, without effect on phosphorylation of IRS1 at serine 307. mTOR-immunoprecipitates from insulin-stimulated adipocytes contains an unidentified protein kinase specific for phosphorylation of IRS1 at serine 307, but it is not mTOR or S6K1.
authors.affiliation: Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
authors.forename: Meenu Rohini
authors.initials: MR
authors.lastname: Rajan
authors.forename: Siri
authors.initials: S
authors.lastname: Fagerholm
authors.forename: Cecilia
authors.initials: C
authors.lastname: Jönsson
authors.forename: Preben
authors.initials: P
authors.lastname: Kjølhede
authors.forename: Maria V
authors.initials: MV
authors.lastname: Turkina
authors.forename: Peter
authors.initials: P
authors.lastname: Strålfors
mesh_terms: D017667:Adipocytes / Q000187:drug effects* / Q000378:metabolism*; D000595:Amino Acid Sequence; D002384:Catalysis; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D007328:Insulin / Q000494:pharmacology*; D055504:Insulin Receptor Substrate Proteins / Q000737:chemistry / Q000378:metabolism*; D008969:Molecular Sequence Data; D009154:Mutation; D010455:Peptides / Q000737:chemistry; D010766:Phosphorylation / Q000187:drug effects; D010879:Piperazines / Q000494:pharmacology; D038762:Ribosomal Protein S6 Kinases, 70-kDa / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D012694:Serine / Q000378:metabolism*; D058570:TOR Serine-Threonine Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism
chemical_list: C526292:IRS1 protein, human; D007093:Imidazoles; D007328:Insulin; D055504:Insulin Receptor Substrate Proteins; C552719:PF-4708671; D010455:Peptides; D010879:Piperazines; D012694:Serine; D038762:Ribosomal Protein S6 Kinases, 70-kDa; D058570:TOR Serine-Threonine Kinases
references.citation: Mol Endocrinol. 2008 Dec;22(12):2729-40
references.pmid: 18927238
references.citation: J Biol Chem. 2009 Aug 21;284(34):22525-34
references.pmid: 19561084
references.citation: Mol Cell Biol. 2006 Sep;26(17):6425-34
references.pmid: 16914728
references.citation: J Biol Chem. 2004 Jan 30;279(5):3447-54
references.pmid: 14623899
references.citation: Cell. 2012 Feb 3;148(3):624, 624.e1
references.pmid: 22304926
references.citation: J Biol Chem. 2007 Jun 22;282(25):18069-18082
references.pmid: 17459875
references.citation: J Biol Chem. 2002 Dec 13;277(50):48115-21
references.pmid: 12351658
references.citation: J Biol Chem. 2006 Mar 17;281(11):7060-7
references.pmid: 16418171
references.citation: Diabetes. 2008 Oct;57(10):2644-51
references.pmid: 18633112
references.citation: Nature. 2004 Sep 9;431(7005):200-5
references.pmid: 15306821
references.citation: J Biol Chem. 2011 Oct 14;286(41):35675-35682
references.pmid: 21852229
references.citation: Sci Signal. 2012 Mar 27;5(217):ra25
references.pmid: 22457331
references.citation: J Cell Biol. 2004 Nov 8;167(3):399-403
references.pmid: 15533996
references.citation: Biochem J. 2010 Oct 15;431(2):245-55
references.pmid: 20704563
references.citation: Endocrinology. 2007 Oct;148(10):4895-905
references.pmid: 17640984
references.citation: Mol Med. 2010 Jul-Aug;16(7-8):235-46
references.pmid: 20386866
references.citation: Diabetologia. 2012 Oct;55(10):2565-2582
references.pmid: 22869320
references.citation: J Biol Chem. 2008 Dec 19;283(51):35375-82
references.pmid: 18952604
references.citation: J Biol Chem. 2001 Dec 14;276(50):46912-6
references.pmid: 11598104
references.citation: J Biol Chem. 1999 Oct 1;274(40):28816-22
references.pmid: 10497255
references.citation: Proc Natl Acad Sci U S A. 2007 Aug 28;104(35):14056-61
references.pmid: 17709744
references.citation: J Biol Chem. 2003 Mar 7;278(10):8199-211
references.pmid: 12510059
references.citation: Endocrinology. 2005 Oct;146(10):4410-6
references.pmid: 16020478
references.citation: J Biol Chem. 2002 Jan 11;277(2):1531-7
references.pmid: 11606564
references.citation: J Cell Biol. 2004 Jul 19;166(2):213-23
references.pmid: 15249583
references.citation: J Biol Chem. 2000 Mar 24;275(12):9047-54
references.pmid: 10722755
references.citation: J Clin Invest. 2001 Jan;107(2):181-9
references.pmid: 11160134
references.citation: FEBS J. 2005 Jan;272(1):141-51
references.pmid: 15634339
references.citation: J Biol Chem. 2005 Oct 14;280(41):34389-92
references.pmid: 16129690
references.citation: Cell Metab. 2005 Aug;2(2):119-29
references.pmid: 16098829
references.citation: Biochem J. 2004 Feb 15;378(Pt 1):105-16
references.pmid: 14583092
references.citation: J Biol Chem. 2008 Apr 25;283(17):11226-33
references.pmid: 18285345
references.citation: Cell Metab. 2006 Jun;3(6):393-402
references.pmid: 16753575
references.citation: J Biol Chem. 2003 Jul 18;278(29):26550-7
references.pmid: 12730242
references.citation: Biochem Biophys Res Commun. 2006 Oct 27;349(3):976-86
references.pmid: 16970908
references.citation: Mol Endocrinol. 2007 Sep;21(9):2294-302
references.pmid: 17579213
references.citation: J Biol Chem. 2002 Dec 27;277(52):50230-6
references.pmid: 12006582
references.citation: J Biol Chem. 2007 Mar 16;282(11):7991-6
references.pmid: 17244624
references.citation: J Biol Chem. 2004 Aug 20;279(34):35298-305
references.pmid: 15199052
references.citation: Cell Metab. 2010 Jan;11(1):84-92
references.pmid: 20074531
references.citation: Diabetologia. 2004 Feb;47(2):170-84
references.pmid: 14722654
references.citation: Eur J Biochem. 1989 Jun 15;182(2):379-85
references.pmid: 2661229